iBio, Inc. (IBIO) reporting calendar
iBio, Inc. files periodic reports with the SEC as IBIO on Nasdaq. Atlas tracks 72 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 17 Jul 2026 – 5 Sep 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 12 May 2026
- Reports on record
- 72
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 42 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open IBIO market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 12 May 2026 | 42 days | 0001104659-26-059416 |
| 10-Q | 31 Dec 2025 | 10 Feb 2026 | 41 days | 0001420720-26-000004 |
| 10-Q | 30 Sep 2025 | 12 Nov 2025 | 43 days | 0001420720-25-000041 |
| 10-K | 30 Jun 2025 | 5 Sep 2025 | 67 days | 0001558370-25-011888 |
| 10-Q | 31 Mar 2025 | 2 May 2025 | 32 days | 0001420720-25-000025 |
| 10-Q | 31 Dec 2024 | 10 Feb 2025 | 41 days | 0001420720-25-000012 |
| 10-Q | 30 Sep 2024 | 12 Nov 2024 | 43 days | 0001420720-24-000054 |
| 10-K | 30 Jun 2024 | 20 Sep 2024 | 82 days | 0001420720-24-000038 |
| 10-Q | 31 Mar 2024 | 13 May 2024 | 43 days | 0001420720-24-000020 |
| 10-Q | 31 Dec 2023 | 9 Feb 2024 | 40 days | 0001558370-24-000934 |
| 10-Q | 30 Sep 2023 | 14 Nov 2023 | 45 days | 0001558370-23-019043 |
| 10-K | 30 Jun 2023 | 27 Sep 2023 | 89 days | 0001420720-23-000045 |
| 10-Q | 31 Mar 2023 | 15 May 2023 | 45 days | 0001558370-23-009707 |
| 10-Q | 31 Dec 2022 | 14 Feb 2023 | 45 days | 0001420720-23-000009 |
| 10-Q | 30 Sep 2022 | 14 Nov 2022 | 45 days | 0001558370-22-017874 |
| 10-K | 30 Jun 2022 | 11 Oct 2022 | 103 days | 0001420720-22-000064 |
| 10-Q | 31 Mar 2022 | 12 May 2022 | 42 days | 0001420720-22-000024 |
| 10-Q | 31 Dec 2021 | 14 Feb 2022 | 45 days | 0001558370-22-001104 |
| 10-Q | 30 Sep 2021 | 15 Nov 2021 | 46 days | 0001558370-21-015986 |
| 10-K | 30 Jun 2021 | 28 Sep 2021 | 90 days | 0001558370-21-012819 |
| 10-Q | 31 Mar 2021 | 17 May 2021 | 47 days | 0001558370-21-007415 |
| 10-Q | 31 Dec 2020 | 16 Feb 2021 | 47 days | 0001104659-21-023996 |
| 10-Q | 30 Sep 2020 | 16 Nov 2020 | 47 days | 0001104659-20-125818 |
| 10-K | 30 Jun 2020 | 13 Oct 2020 | 105 days | 0001104659-20-114567 |
| 10-Q | 31 Mar 2020 | 15 May 2020 | 45 days | 0001104659-20-062716 |
| 10-Q | 31 Dec 2019 | 14 Feb 2020 | 45 days | 0001104659-20-020473 |
| 10-Q | 30 Sep 2019 | 14 Nov 2019 | 45 days | 0001104659-19-064178 |
| 10-K | 30 Jun 2019 | 26 Aug 2019 | 57 days | 0001144204-19-041659 |
| 10-Q | 31 Mar 2019 | 10 May 2019 | 40 days | 0001144204-19-025332 |
| 10-Q | 31 Dec 2018 | 13 Feb 2019 | 44 days | 0001144204-19-007128 |
| 10-Q | 30 Sep 2018 | 13 Nov 2018 | 44 days | 0001144204-18-059349 |
| 10-K | 30 Jun 2018 | 18 Sep 2018 | 80 days | 0001144204-18-049866 |
| 10-Q | 31 Mar 2018 | 11 May 2018 | 41 days | 0001144204-18-027689 |
| 10-Q | 31 Dec 2017 | 14 Feb 2018 | 45 days | 0001144204-18-009023 |
| 10-Q | 30 Sep 2017 | 9 Nov 2017 | 40 days | 0001144204-17-057708 |
| 10-K | 30 Jun 2017 | 15 Sep 2017 | 77 days | 0001144204-17-048249 |
| 10-Q | 31 Mar 2017 | 15 May 2017 | 45 days | 0001144204-17-027544 |
| 10-Q | 31 Dec 2016 | 21 Feb 2017 | 52 days | 0001144204-17-010136 |
| 10-Q | 30 Sep 2016 | 18 Nov 2016 | 49 days | 0001144204-16-135413 |
| 10-K | 30 Jun 2016 | 13 Oct 2016 | 105 days | 0001144204-16-127993 |
Source: SEC EDGAR company submissions for CIK 0001420720. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.